| 000 | 01745 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517194438.0 | ||
| 264 | 0 | _c20180905 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1875-6638 | ||
| 024 | 7 |
_a10.2174/1573406414666180112115201 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToumpeki, Chrisavgi | |
| 245 | 0 | 0 |
_aConstruction of an M1GS Ribozyme for Targeted and Rapid mRNA Cleavage; Application on the Ets-2 Oncogene. _h[electronic resource] |
| 260 |
_bMedicinal chemistry (Shariqah (United Arab Emirates)) _c2018 |
||
| 300 |
_a604-616 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-4 _xmetabolism |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 |
_aOncogenes _xgenetics |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aProto-Oncogene Protein c-ets-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Catalytic _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRibonuclease P _xgenetics |
| 650 | 0 | 4 |
_aSpiramycin _xpharmacology |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aAnastasakis, Dimitrios | |
| 700 | 1 | _aPanagoulias, Ioannis | |
| 700 | 1 | _aStamatopoulou, Vassiliki | |
| 700 | 1 | _aGeorgakopoulos, Tassos | |
| 700 | 1 | _aKallia-Raftopoulos, Sofia | |
| 700 | 1 | _aMouzaki, Athanasia | |
| 700 | 1 | _aDrainas, Denis | |
| 773 | 0 |
_tMedicinal chemistry (Shariqah (United Arab Emirates)) _gvol. 14 _gno. 6 _gp. 604-616 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1573406414666180112115201 _zAvailable from publisher's website |
| 999 |
_c27978596 _d27978596 |
||